Clinical Research Protocols & Pharmaceutical Guidelines
At GLI Team, our research framework is built upon the pillars of scientific integrity, patient safety, and global regulatory compliance. We adhere to the most stringent international standards to ensure that our pharmaceutical insights and clinical data are both reproducible and ethically sound.
1. Good Clinical Practice (GCP) Standards
Our clinical research methodologies are strictly aligned with the ICH-GCP (International Council for Harmonisation – Good Clinical Practice). These guidelines provide a unified standard for the European Union, Japan, the United States, and now widely adopted globally in 2026.
- Ethical Conduct: All research is conducted in accordance with the Declaration of Helsinki.
- Data Integrity: We implement robust ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) principles for all clinical data management.
- Participant Safety: Prioritizing the rights, safety, and well-being of trial participants above all scientific interests.
2. Regulatory Compliance Framework (2026 Updated)
To facilitate international pharmaceutical collaboration, we maintain strict adherence to the updated 2026 frameworks provided by major regulatory bodies:
Food and Drug Administration (FDA)
We follow the FDA Modernization Act 2.0 regarding the use of alternative methods to animal testing, including organ-on-a-chip and advanced “In Silico” modeling for drug toxicity reports.
European Medicines Agency (EMA)
Our protocols for decentralized clinical trials are compliant with the EMA’s Recommendation Paper on Decentralised Elements in Clinical Trials, ensuring secure data transmission and remote patient monitoring ethics.
3. Standard Operating Procedures (SOPs)
Every project under the GLI Team umbrella undergoes a multi-stage review process:
| Stage | Focus Area | Compliance Target |
| Phase I | Molecular Screening | In Silico Validation |
| Phase II | Toxicity Assessment | ISO 10993 Standards |
| Phase III | Clinical Efficacy | Double-Blind Randomized Control |
| Review | Ethical Audit | IRB / IEC Approval |
4. Global Scientific Resources & External References
For researchers and academic partners seeking more detailed regulatory documentation, we recommend consulting the following global authorities:
- World Health Organization (WHO): International Clinical Trials Registry Platform (ICTRP)
- PubMed / National Institutes of Health (NIH): Pharmacological Research Database
- ICH Official Site: Guideline for Good Clinical Practice
5. Our Commitment to Transparency
Transparency is the foundation of trust in pharmaceutical research. GLI Team commits to publishing both positive and negative results from our research initiatives to combat publication bias. We believe that sharing comprehensive data—regardless of the outcome—is essential for the collective advancement of global medicine.
Editorial Note: These guidelines are reviewed bi-annually by the GLI Team Editorial Board to reflect changes in international law and scientific breakthroughs.